ExoCoBio Overview
- Year Founded
-
2017
- Status
-
Private
- Employees
-
104
- Latest Deal Type
-
2ndary - Private
- (In Progress)
- Latest Deal Amount
-
$71.9K
- Investors
-
21
ExoCoBio General Information
Description
Developer of regenerative medicine and biopharmaceuticals designed to create value for the healthy life of mankind. The company's products specialize in the development of stem cell-derived exosome therapeutics which are nano-vesicles secreted by cells for intercellular signalings for the growth of skin and hair, enabling clinicians to develop stimulation of cellular tissue regeneration technology alternatives.
Contact Information
Website
exocobio.comCorporate Office
- 18th Daeryung Techno Town
- 19, Gasan digital 1-ro, Geumcheon-gu
- Seoul
- South Korea
Corporate Office
- 18th Daeryung Techno Town
- 19, Gasan digital 1-ro, Geumcheon-gu
- Seoul
- South Korea
ExoCoBio Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Secondary Transaction - Private | 12-Sep-2025 | $71.9K | In Progress | Profitable | ||
| 5. Later Stage VC (Series C) | 02-Nov-2023 | Completed | Generating Revenue | |||
| 4. Later Stage VC (Series C) | 25-Aug-2020 | Completed | Generating Revenue | |||
| 3. Early Stage VC (Series B) | 12-Sep-2018 | Completed | Startup | |||
| 2. Early Stage VC | $8M | $19M | Completed | Startup | ||
| 1. Early Stage VC (Series A) | 02-May-2017 | $11M | $11M | Completed | Startup |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
ExoCoBio Comparisons
Industry
Financing
Details
ExoCoBio Competitors (30)
One of ExoCoBio’s 30 competitors is Histogen, a Formerly VC-backed company based in San Ramon, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Histogen | Formerly VC-backed | San Ramon, CA | ||||
| PIPr Therapeutics | Venture Capital-Backed | Durham, NC | ||||
| S-Biomedic | Formerly VC-backed | Ghent, Belgium | ||||
| Azitra | Formerly VC-backed | Branford, CT | ||||
| Aquapharm Biodiscovery | Formerly VC-backed | Oban, United Kingdom |
ExoCoBio Patents
ExoCoBio Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2025037785-A1 | Novel composition comprising actinidia polygama-derived exosomes as active ingredient | Inactive | 11-Aug-2023 | ||
| EP-4663749-A1 | Method for promoting secretion of exosomes from animal cells by using rose-derived exosomes | Pending | 30-Mar-2023 | ||
| EP-4663749-A4 | Method for promoting secretion of exosomes from animal cells by using rose-derived exosomes | Pending | 30-Mar-2023 | ||
| US-20250368951-A1 | Method for promoting secretion of exosomes from animal cells by using rose-derived exosomes | Pending | 30-Mar-2023 | ||
| WO-2024204971-A1 | Method for promoting secretion of exosomes from animal cells by using rose-derived exosomes | Inactive | 30-Mar-2023 | C12N5/0667 |
ExoCoBio Signals
ExoCoBio Investors (21)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Hana S&B Investment | PE/Buyout | Majority | ||
| TKG Ventures | Venture Capital | Minority | ||
| Focus Assets Management | Asset Manager | Minority | ||
| G.N. Tech Venture Capital | Venture Capital | Minority | ||
| HLB bioStep Company | Corporation | Minority |
ExoCoBio Acquisitions (1)
ExoCoBio’s most recent deal was a Merger/Acquisition with BENEV. The deal was made on 12-Jul-2023.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| BENEV | 12-Jul-2023 | Merger/Acquisition | Other Devices and Supplies |
ExoCoBio Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| BENEV | Mission Viejo, CA | 2000 |
ExoCoBio FAQs
-
When was ExoCoBio founded?
ExoCoBio was founded in 2017.
-
Where is ExoCoBio headquartered?
ExoCoBio is headquartered in Seoul, South Korea.
-
What is the size of ExoCoBio?
ExoCoBio has 104 total employees.
-
What industry is ExoCoBio in?
ExoCoBio’s primary industry is Drug Discovery.
-
Is ExoCoBio a private or public company?
ExoCoBio is a Private company.
-
What is the current valuation of ExoCoBio?
The current valuation of ExoCoBio is .
-
What is ExoCoBio’s current revenue?
The current revenue for ExoCoBio is .
-
How much funding has ExoCoBio raised over time?
ExoCoBio has raised $55.3M.
-
Who are ExoCoBio’s investors?
Hana S&B Investment, TKG Ventures, Focus Assets Management, G.N. Tech Venture Capital, and HLB bioStep Company are 5 of 21 investors who have invested in ExoCoBio.
-
Who are ExoCoBio’s competitors?
Histogen, PIPr Therapeutics, S-Biomedic, Azitra, and Aquapharm Biodiscovery are some of the 30 competitors of ExoCoBio.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process